Search Results 721-730 of 13491 for monoclonal antibody
UP-NEXT is a double-blind, randomized, placebo controlled study of the antibody ... Immunotherapy with monoclonal antibodies, such as durvalumab, may help the ...
... monoclonal antibody, to decrease dose-reducing toxicities. In the phase 1 trial, researchers observed reduced markers of toxicities and no new safety issues ...
Kunamneni develops multiple technology platforms to discover new single-chain variable fragment and monoclonal antibodies. ... antibody humanization and antibody ...
Monoclonal antibodies, such as obinutuzumab, may interfere with the ability of cancer cells to grow and spread. It is not yet known whether giving ...
Immunotherapy with monoclonal antibodies, such as nivolumab, may help the body's immune system attack the cancer, and may interfere with the ability of ...
Monoclonal antibodies, such as atezolizumab, may block tumor growth in ... Denosumab is a monoclonal antibody that is used to treat bone loss in order ...
About this study ... Depemokimab is a humanised, affinity matured monoclonal antibody that blocks human interleukin-5 (IL-5) binding to its receptor. Depemokimab ...
A monoclonal antibody, lecanemab, shows promise in removing amyloid plaques from the brain, according to phase 3 trial results. Amyloid plaques are one of ...
The list of medications associated with hypogammaglobulinemia includes chronic glucocorticosteroids and sulfasalazine, anti-CD20 monoclonal antibodies ( ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Mayo Clinic researchers drive discoveries that improve detection, diagnosis and treatment. Your quick message to them means so much.